Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients

ES Park, AR Lee, DH Kim, JH Lee, JJ Yoo, SH Ahn… - Journal of …, 2019 - Elsevier
Background & Aims Tenofovir disoproxil fumarate (TDF) is one the most potent nucleot (s)
ide analogues for treating chronic hepatitis B virus (HBV) infection. Phenotypic resistance …
被引用次数：138 相关文章

Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients.

ES Park, AR Lee, DH Kim, JH Lee, JJ Yoo… - Journal of …, 2019 - europepmc.org
Methods Two patients with viral breakthrough during treatment with TDF-containing
regimens were prospectively enrolled. The gene encoding HBV reverse transcriptase was …

Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients

ES Park, AR Lee, DH Kim, JH Lee, JJ Yoo… - Journal of …, 2019 - pure.kaist.ac.kr
Background & Aims: Tenofovir disoproxil fumarate (TDF) is one the most potent nucleot (s)
ide analogues for treating chronic hepatitis B virus (HBV) infection. Phenotypic resistance …

Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients

ES Park, AR Lee, DH Kim, JH Lee… - Journal of …, 2019 - snucm.elsevierpure.com
Background & Aims: Tenofovir disoproxil fumarate (TDF) is one the most potent nucleot (s)
ide analogues for treating chronic hepatitis B virus (HBV) infection. Phenotypic resistance …

Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients

ES Park, AR Lee, DH Kim, JH Lee, JJ Yoo… - Journal of …, 2019 - hal.science
Background & aims: Tenofovir disoproxil fumarate (TDF) is one the most potent nucleot (s)
ide analogues for treating chronic hepatitis B virus (HBV) infection. Phenotypic resistance …

Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients

ES Park, AR Lee, DH Kim, JH Lee… - Journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Background & aims Tenofovir disoproxil fumarate (TDF) is one the most potent nucleot (s)
ide analogues for treating chronic hepatitis B virus (HBV) infection. Phenotypic resistance …

Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients

ES Park, AR Lee, DH Kim, JH Lee… - Journal of …, 2019 - journal-of-hepatology.eu
Background & Aims Tenofovir disoproxil fumarate (TDF) is one the most potent nucleot (s)
ide analogues for treating chronic hepatitis B virus (HBV) infection. Phenotypic resistance …

Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients

ES Park, AR Lee, DH Kim, JH Lee, JJ Yoo… - Journal of …, 2019 - pure.korea.ac.kr
Background & Aims: Tenofovir disoproxil fumarate (TDF) is one the most potent nucleot (s)
ide analogues for treating chronic hepatitis B virus (HBV) infection. Phenotypic resistance …
[PDF] researchgate.net

[PDF][PDF] Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients

ES Park, AR Lee, DH Kim, JH Lee, JH Yoon, F Zoulim… - 2019 - researchgate.net
Background & Aims: Tenofovir disoproxil fumarate (TDF) is one the most potent nucleot (s)
ide analogues for treating chronic hepatitis B virus (HBV) infection. Phenotypic resistance …

Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients

ES Park, AR Lee, DH Kim, JH Lee, JJ Yoo, SH Ahn… - 2019 - scholarworks.bwise.kr
Background & Aims: Tenofovir disoproxil fumarate (TDF) is one the most potent nucleot (s)
ide analogues for treating chronic hepatitis B virus (HBV) infection. Phenotypic resistance …